“it might be challenging to prove apples-to-apples superiority over remdesivir which cut recovery time for patients hospitalized with COVID-19 by 4 days.“

Careful, you’re giving Remdesevir much more credit then it is due. The drug reduced hospitalization in only hospitalized patients who were on supplemental oxygen. Not those on high flow oxygen, ventilator, etc.

They cherry picked that endpoint.